Boston An independent LDT provider

Press releases

August 12, 2024 | REGULATORY

Immunovia publishes prospectus in connection with forthcoming rights issue

Read press release
August 6, 2024 | REGULATORY

Immunovia announces final terms of rights issue

Read press release
August 5, 2024 | REGULATORY

Immunovia Publishes Interim Report for January-June 2024

Read press release
August 5, 2024

Immunovia’s next generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health

Read press release
August 2, 2024

Immunovia files US patent application to protect its next-generation test

Read press release
August 1, 2024

Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy

Read press release
July 29, 2024

Invitation to Immunovia’s Q2 presentation

Read press release
July 25, 2024

Immunovia presents data from discovery study at 2024 PancreasFest medical conference

Read press release
July 2, 2024

Immunovia’s new lab staffed and operational after rapid implementation

Read press release
June 19, 2024 | REGULATORY

BULLETIN FROM THE ANNUAL GENERAL MEETING ON 19 JUNE 2024 IN IMMUNOVIA AB (PUBL)

Read press release
May 20, 2024 | REGULATORY

NOTICE OF ANNUAL GENERAL MEETING IN IMMUNOVIA AB (PUBL)

Read press release
May 20, 2024

Immunovia carries out a rights issue of units of approximately SEK 70 million and raises bridge loans

Read press release
1 2 3 4 30